MSB 6.84% $1.02 mesoblast limited

Some good results from other tests on heart issues using stem...

  1. 4,180 Posts.
    lightbulb Created with Sketch. 5443
    Some good results from other tests on heart issues using stem cells.

    https://www.dicardiology.com/content/stem-cell-therapy-improved-quality-life-patients-microvascular-dysfunction

    "This was a proof of concept trial to evaluate the safety and efficacy of CD34+ stem cells administered via intracoronary infusion for CMD patients with abnormal coronary flow reserve of less than 2.5,” said Timothy D. Henry, M.D., MSCAI, lead author of the study and SCAI vice president. “Our results demonstrate a significant improvement in coronary flow reserve with a single intracoronary infusion of CD34+ cells as well as a significant improvement in angina and quality of life.”

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.02
Change
0.065(6.84%)
Mkt cap ! $1.124B
Open High Low Value Volume
95.5¢ $1.03 95.0¢ $5.562M 5.551M

Buyers (Bids)

No. Vol. Price($)
17 53986 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.02 20390 4
View Market Depth
Last trade - 15.26pm 30/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.